Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 15 of 15

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Reduction of pathological retinal neovascularization, vessel obliteration and artery tortuosity by PEDF protein-based therapeutic in an oxygen-induced ischemic retinopathy rat model

SHIYING ZHAO; Alexander Tschulakow; Subha Karthikeyan; Kun Wang; Stefan Kochanek; Ulrich Schraermeyer; Sylvie Julien-Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):284.

ARVO Annual Meeting Abstract June 2023

Pigment epithelium-derived factor (PEDF) based therapy induced photoreceptor survival by stabilising the neovessels in a VEGF overexpression CNV rat model

Alexander Viktor Tschulakow; Lei Xi; Ulrich Schraermeyer; Sylvie Julien-Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1133.

ARVO Annual Meeting Abstract July 2019

Stabilization and supporting blood vessel growth as a new concept to treat wet AMD

Sylvie Julien; Alexander Tschulakow; Harsh Thakkar; Shan Liu; Barbara Illing; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):366.

ARVO Annual Meeting Abstract July 2019

Degradation of lipofuscin in Stargardt mice can be enhanced by the superoxide generator riboflavin - a hypothesis for melanolipofuscin formation

Ulrich Schraermeyer; Yuan Fang; Tatjana Taubitz; Alexander Tschulakow

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1912.

ARVO Annual Meeting Abstract July 2019

The three dimensional (3D) ultrastructure of VEGF driven choroidal neovascularisation in the rat

Antje Biesemeier; Shan Liu; Alexander Tschulakow; Barbara Illing; Harsh Thakkar; Yuan Fang; Birgit Schroeppel; Claus Burkhardt; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2980.

ARVO Annual Meeting Abstract July 2019

Short-wavelength and near-Infrared fundus autofluorescence in blue light-illuminated Abca4 -/- mice and a patient with Stargardt disease

Yuan Fang; Alexander Tschulakow; Tatjana Taubitz; Barbara Illing; Antonina Burda; Antje Biesemeier; Sylvie Julien; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5982.

ARVO Annual Meeting Abstract June 2017

Preclinical results of a new pharmacological therapy approach for Stargardt disease and dry age-related macular degeneration

Yuan Fang; Alexander Tschulakow; Marina Tikhonovich; Tatjana Taubitz; Barbara Illing; Sigrid Schultheiss; Ulrich Schraermeyer; Sylvie Julien-Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):256.

ARVO Annual Meeting Abstract June 2017

Unravelling the mystery of the Stiles Crawford Effect

Ulrich Schraermeyer; Sigrid Schultheiss; Theo Oltrup; Thomas Bende; Sebastian Schmelzle; Alexander Tschulakow

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5603.

ARVO Annual Meeting Abstract June 2017

Effect of the pre-treatment with the radioprotector ortho-phospho-L-tyrosine (pTyr) in a xenograft retinoblastoma mouse model

Alexander Viktor Tschulakow; H. Peter Rodemann; Stephan M. Huber; Monika Rittgarn; Dominik Klumpp; Benjamin Steegen; Ulrich Schraermeyer; Sylvie Julien-Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1775.

ARVO Annual Meeting Abstract June 2017

A valid ultrastructural rat choroidal neovascularization model developed by overexpression of VEGF

Shan Liu; Alexander Viktor Tschulakow; Sylvie Julien-Schraermeyer; Ulrich Schraermeyer; Antje Kristina Biesemeier

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2269.

ARVO Annual Meeting Abstract June 2015

Effects of pretreatment with the radioprotector ortho-phospho-L-tyrosine (pTyr) on Rb+/- mice after radiation exposure - Implication for the treatment of retinoblastoma patients with radiotherapy

Alexander Tschulakow; Stephan Huber; Monika Rittgarn; Hans-Peter Rodemann; Ulrich Schraermeyer; Sylvie Julien; Section of Experimental Vitreoretinal Surgery, Center for Ophthalmology, Tuebingen, Germany

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):72.

ARVO Annual Meeting Abstract June 2015

Intravitreal injection of Fc-fragments has multiple adverse effects on retina and choroid

Ulrich Schraermeyer; Tatjana Taubitz; Laura-Pia Steinbrenner; Tobias Peters; Antje Kristina Biesemeier; Monika Rittgarn; Sigrid Schultheiss; Alexander Tschulakow; Sylvie Julien

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1511.

ARVO Annual Meeting Abstract June 2015

Removal of lipofuscin from the RPE of Abca4 -/- mice with THPE: quantitative and toxicity studies

Tatjana Taubitz; Tobias Peters; Simone Pöschel; Alexander Tschulakow; Monika Rittgarn; Sigrid Schultheiss; Katja Schenke-Layland; Michael Burnet; Sylvie Julien; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4199.

ARVO Annual Meeting Abstract April 2014

Effects of a single intravitreal injection of aflibercept and ranibizumab on glomeruli of monkeys

Sylvie Julien; Alexander Viktor Tschulakow; Sarah Christner; Ulrich Schraermeyer

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1946.

ARVO Annual Meeting Abstract April 2014

Establishment of a new retinoblastoma mouse model by intravitreal injection of human retinoblastoma Y79 cells into nude mice eyes - Comparison of SLO/OCT vs. histological follow up

Alexander Viktor Tschulakow; Hans-Peter Rodemann; Ulrich Schraermeyer; Sylvie Julien

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3074.

Advertisement